Electra Therapeutics, Inc. Common stock (ETRA) — Defensive Interval Ratio
Electra Therapeutics, Inc. Common stock (ETRA) has a Defensive Interval Ratio of 836 days as of June 2026. Defensive assets of $31.22 Million (cash $-, short-term investments $31.22 Million, receivables $-) cover 836 days of daily cash needs of $37.33K/day. See ETRA current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Electra Therapeutics, Inc. Common stock Defensive Interval Ratio (2024–2025)
This chart shows how Electra Therapeutics, Inc. Common stock's Defensive Interval Ratio has evolved across 2 annual periods from 2024 to 2025. As of June 2026, the ratio stands at 836 days, meaning defensive assets of $31.22 Million can fund 836 days of operations without new revenue. Read Electra Therapeutics, Inc. Common stock (ETRA) financial obligations for a breakdown of total debt and financial obligations.
Annual Defensive Interval Ratio for Electra Therapeutics, Inc. Common stock (2024–2025)
The table below presents the year-by-year Defensive Interval Ratio for Electra Therapeutics, Inc. Common stock from 2024 to 2025, covering 2 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For the complete balance sheet picture, see Electra Therapeutics, Inc. Common stock balance sheet assets.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 2008 days | $53.51 Million | $26.65K/day | $- | $53.51 Million | ▲ +1921 days |
| 2024 | 87 days | $998.00K | $11.49K/day | $- | $998.00K | — |